Aging
Navigate
Submit an Article
Research Paper|Volume 12, Issue 20|pp. 20835–20861
SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
Back to articleFigure 7(7 of 9)
100%
Figure 7
Figure 7.SMARCD3 expression is positively correlated with metastasis, TGF-β pathway activation and Mesenchymal signatures.